Image de couverture de livre

Tracing the Evolutionary Pathway of SARS-CoV-2 Through RNA Sequencing Analysis

Fuente: Zenodo

Enregistré dans:

Détails bibliographiques
Auteur principal:	Mostafa, Rezapour
Format:	Recurso digital
Publié:	Zenodo 2025
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

PETRA: Pretrained Evolutionary Transformer for SARS-CoV-2 Mutation Prediction
par: Zou, Xu
Publié: (2025)

Developing Allosteric Inhibitors of SARS‐CoV‐2 RNA‐Dependent RNA Polymerase
par: Artem Chayka, et autres
Publié: (2024)

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
par: Kuldeep Singh Patel
Publié: (2020)

Bayesian Re-Analysis of the Phylogenetic Topology of Early SARS-CoV-2 Case Sequences
par: Weissman, Michael B.
Publié: (2025)

Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens
par: Swapna Thomas, et autres
Publié: (2024)

Tool Choice Matters: Evaluating edgeR vs. DESeq2 for Sensitivity, Robustness, and Cross-Study Performance
par: Rezapour, Mostafa
Publié: (2026)

Torsional twist of the SARS ‐ CoV and SARS ‐ CoV ‐2 SUD ‐N and SUD ‐M domains
par: Monica Rosas‐Lemus, et autres
Publié: (2025)

Humoral epitope dominance and immune imprinting by SARS ‐ CoV ‐1 and SARS ‐ CoV ‐2 vaccines
par: Deborah L Burnett, et autres
Publié: (2026)

2024 SARS-CoV-2 Sequences with Diagnostic Primer/Probe Mismatch Profiles
par: Bhatti, Tahir
Publié: (2025)

SARS-CoV-2 and Saliva: an update
par: Muniz, Isis de Araújo Ferreira, et autres
Publié: (2020)

Structural Immunology of SARS‐CoV‐2
par: Meng Yuan, et autres
Publié: (2024)

Demografía y SARS-CoV-2
par: Manuel Ordorica Mellado
Publié: (2021)

Pandemia por SARS-CoV-2
par: Erina Petrera
Publié: (2020)

Allosteric Inhibitors of SARS‐CoV‐2 RNA‐Dependent RNA Polymerase Based on N , N′ ‐Diphenylurea
par: Artem Chayka, et autres
Publié: (2025)

Multiscale characterization of natural amino acid substitutions in RNA-dependent RNA polymerase of SARS-CoV-2
par: Danda, Matěj, et autres
Publié: (2024)

Detection of SARS‐CoV‐2 Virions and RNA in Aerosols From COVID‐19 Environments
par: Consuelo Ferrer, et autres
Publié: (2025)

SARS ‐ CoV ‐2 nucleocapsid protein variants have differential RNA chaperone activity
par: Sabrina Babl, et autres
Publié: (2025)

SARS-CoV-2 and ACE2 nexus
par: Arifuddin, Mehnaaz Sameera
Publié: (2020)

Analytical Performance of a Novel Nanopore Sequencing for SARS‐CoV‐2 Genomic Surveillance
par: Mulatijiang Maimaiti, et autres
Publié: (2024)

Phylogeography of horseshoe bat sarbecoviruses in Vietnam and neighbouring countries. Implications for the origins of SARS ‐ CoV and SARS ‐ CoV ‐2
par: Alexandre Hassanin, et autres
Publié: (2024)

Rethinking Optimal Immunogens to Face SARS‐CoV‐2 Evolution Through Vaccination
par: Julià Blanco, et autres
Publié: (2025)

Coronavirus 2: Analysis of Regularity of Complete Genome (SARS-CoV-2/Hu/DP/Kng/19-020 RNA)
par: Morales-López, Yuri, et autres
Publié: (2020)

SARS-CoV-2: a clinical update
par: da Silveira Cespedes, Mateus, et autres
Publié: (2020)

COVID-19 y SARS-CoV-2
par: Alfredo Pinzón-Junca
Publié: (2020)

SARS-CoV-2 y aparato digestivo
par: Iván Carabaño Aguado
Publié: (2020)

Non‐Neutralising Antibodies and T Cell Responses to SARS ‐ CoV ‐2 Detected in Unvaccinated SARS ‐ CoV ‐2‐Naive Spanish Adolescents
par: Hector F. Pelaez‐Prestel, et autres
Publié: (2025)

SARS‐CoV‐2 nucleocapsid antigen in plasma of children hospitalized for COVID‐19 or with incidental detection of SARS‐CoV‐2 infection
par: Nicolas Capelli, et autres
Publié: (2024)

Bioorthogonal RNase L Recruitment Enables Targeted Inducible Degradation of SARS‐CoV‐2 RNA
par: Wei Xiong, et autres
Publié: (2025)

Bioorthogonal RNase L Recruitment Enables Targeted Inducible Degradation of SARS‐CoV‐2 RNA
par: Wei Xiong, et autres
Publié: (2025)

Neonatal SARS‐CoV‐2 mRNA Vaccination Efficacy Is Influenced by Maternal Antibodies: Correspondence
par: Hinpetch Daungsupawong, et autres
Publié: (2024)

A snapshot of SARS‐CoV‐2 viral RNA throughout wastewater treatment plants in Arkansas
par: Aaron Long, et autres
Publié: (2024)

Optimization of a DNA‐launched SARS‐CoV‐2 replicon with RNA splicing inhibitor Isoginkgetin
par: Hu Zhang, et autres
Publié: (2024)

Digital droplet RT‐LAMP increases speed of SARS‐CoV‐2 viral RNA detection
par: Yuan Yuan, et autres
Publié: (2024)

A SARS-CoV-2 Interaction Dataset and VHH Sequence Corpus for Antibody Language Models
par: Tsuruta, Hirofumi, et autres
Publié: (2024)

Novel Strategies to Profile SARS‐CoV‐2 and Human Lung Proteome: Inflammatory Pathways in the Spotlight
par: E. Mankayi, et autres
Publié: (2025)

An efficient strategy for producing RNA ‐free Nucleocapsid protein of SARS ‐ CoV ‐2 for biochemical and structural investigations
par: Shweta Singh, et autres
Publié: (2025)

Pharmacokinetics of SARS‐CoV‐2 RNA Polymerase Inhibitor Remdesivir in Participants With Moderate and Severe Hepatic Impairment
par: Sean Regan, et autres
Publié: (2025)

Optimization of Structure‐Guided Development of Chemical Probes for the Pseudoknot RNA of the Frameshift Element in SARS‐CoV‐2
par: Betül Ceylan, et autres
Publié: (2025)

Optimization of Structure‐Guided Development of Chemical Probes for the Pseudoknot RNA of the Frameshift Element in SARS‐CoV‐2
par: Betül Ceylan, et autres
Publié: (2025)

Unraveling the Mechanism of Drug Binding to SARS-CoV-2 RNA Pseudoknot with Thermodynamics-Driven Machine Learning
par: Ivonina, Mariia, et autres
Publié: (2026)